The Dementias and Neurodegeneration (DeNDRoN) specialty supports the set up and delivery of clinical research in the NHS in a range of dementia and neurodegenerative diseases. Our job is to ensure that studies into dementias and neurodegeneration that are included in our national portfolio of research receive the right support to make sure they are delivered successfully in the NHS.

The Government’s Challenge on Dementia sets out the ambition for England to be the best place in the world to undertake research into dementia and other neurodegenerative diseases by 2020.  UK Dementia research is fully embedded in NHS clinical practice. Expertise exists in all stages and types of dementia, from pre-symptomatic through mild cognitive impairment to more advance stages. This includes Alzheimer’s disease, Lewy body dementias, vascular cognitive impairment, mixed dementias, frontotemporal dementia and other less common forms. Studies span the full translational research pathway.

Neurodegeneration as part of the Dementia and Neurodegenerative Diseases (DeNDRoN) Specialty, is made up of leading research-interested clinicians and practitioners at both national and local levels. We support studies in neurodegenerative conditions such as Parkinson’s, Huntington’s and Motor Neurone Disease and ensure they are delivered to time and target.